Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01C
- Chemical subgroupC01CA
- Chemical substanceC01CA04Dopamine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 23 registrations
- Cloridrato de dopaminaHipolabor Farmaceutica Ltda
- Cloridrato de DopaminaHypofarma - Instituto de Hypodermia e Farmácia Ltda
- Cloridrato de DopaminaUnião Química Farmacêutica Nacional S/A
- Cloridrato de DopaminaLaboratório Teuto Brasileiro S/A
United States
FDA · 21 registrations
At a glance
- ATC code
- C01CA04
- ATC group
- Cardiovascular system
- Registers
- 10
- Historical lists
- 2
- Registrations
- 81
- With their own page
- 45
- Companies
- 44
All medicines with Dopamine
Human medicines from every register that match Dopamine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
84 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dopamine Hydrochloride | United States | 160MG/100ML, 160MG/ML, 40MG/ML … | injectable | Marketed | Warner Chilcott |
| Dopamine Basi | New Zealand | Inj 40 mg per ml, 5 ml ampoule | Funded | ||
| Dopamine Hydrochloride in Dextrose 5% in Plastic Container | United States | 160MG/100ML, 320MG/100ML, 640MG/100ML … | injectable | Marketed | Hospira |
| Dopamine HCL 0.8MG/ML Dextrose 5% Inj USPCombination | Canada | 50 MG / ML + 0.8 MG / ML | Solution | Marketed | Baxter Corporation |
| Dopamine HCL 1.6MG/ML Dextrose 5% Inj USPCombination | Canada | 50 MG / ML + 1.6 MG / ML | Solution | Marketed | Baxter Corporation |
| Dopamine HCL 3.2MG/ML Dextrose 5% Inj USPCombination | Canada | 50 MG / ML + 3.2 MG / ML | Solution | Marketed | Baxter Corporation |
| Dopaminehydrochloride Hikma 40 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Hikma Farmaceutica (Portugal), S.A. | |
| Dopamine Hydrochloride in Dextrose 5% | United States | 1.6MG/ML | injectable | Not marketed | Hospira |
| Dopamine Hydrochloride and Dextrose 5% | United States | 320MG/100ML, 80MG/100ML | injectable | Not marketed | B Braun |
| Dopamine Hydrochloride and Dextrose 5% in Plastic Container | United States | 160MG/100ML, 40MG/100ML | injectable | Not marketed | B Braun |
| Dopamine HCL 200MG-5ML Amp | Saudi Arabia | Authorised | Hospira Australia | ||
| Dopamine Fresenius 200 mg/5 ml | Saudi Arabia | Authorised | Fresenius Kabi Austria GmbH | ||
| Intropin | United States | 160MG/ML, 40MG/ML, 80MG/ML | injectable | Not marketed | Hospira |
| Dopabane | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| DOPAMINA GRIFOLS 200 mg SOLUCIÓN INYECTABLE | Spain | 200 mg | solución inyectable | Marketed | Laboratorios Grifols S.A. |
| Cloridrato de dopamina | Brazil | Authorised | Hipolabor Farmaceutica Ltda | ||
| Cloridrato de Dopamina | Brazil | Authorised | Hypofarma - Instituto de Hypodermia e Farmácia Ltda | ||
| Cloridrato de Dopamina | Brazil | Authorised | União Química Farmacêutica Nacional S/A | ||
| Cloridrato de Dopamina | Brazil | Authorised | Laboratório Teuto Brasileiro S/A | ||
| Dopacris | Brazil | Authorised | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Dopamina Basi 40 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 40 mg/ml | concentrado para solución para perfusión | Marketed | Laboratorios Basi Industria Farmaceutica S.A. |
| Neoatricon | European Union | Authorised | BrePco Biopharma Limited | ||
| Neoatricon 1,5 MG/ML Solucion Para Perfusion | Spain | 45 mg | solución para perfusión | Marketed | Brepco Biopharma Limited |
| Neoatricon 4,5 MG/ML Solucion Para Perfusion | Spain | 225 mg | solución para perfusión | Marketed | Brepco Biopharma Limited |
| Neoatricon 1,5 mg/ml oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | BrePco Biopharma Limited |